Iovance Biotherapeutics Inc (NAS:IOVA)
$ 9.32 -0.08 (-0.85%) Market Cap: 2.84 Bil Enterprise Value: 2.52 Bil PE Ratio: 0 PB Ratio: 3.67 GF Score: 39/100

Iovance Biotherapeutics Inc at H C Wainwright Global Life Sciences Conference (Virtual)- Panel Transcript

Mar 09, 2021 / 06:00PM GMT
Release Date Price: $34.47 (+9.19%)
Michael Evan Meyers
H.C. Wainwright & Co., LLC - Vice Chairman, Head of M&A and Strategic Advisory Services

Welcome to our panelists, corporate and investment clients. I wish all a healthy and productive remainder of the first quarter. I'm Michael Meyers, Vice Chair, Head of M&A and Strategic Advisory Services at H.C. Wainwright. On behalf of John Chambers, our President and Head of Investment Banking; Richard Gormley, our Vice Chair and President of Capital Markets and all of our colleagues at H.C. Wainwright, it's my great pleasure to welcome you to our Global Life Sciences Conference.

This conference follows our 22nd Annual Global Investors Conference in September and our BioConnect 2021 Conference in January. And while the venues have been quite different for all of us since March of last year, we look forward to offering you a rich virtual content over the next 4 days -- 2 days, excuse me, to include our panel of this afternoon and virtual wine tour and tasting of this evening.

With that, I would now like to introduce our moderator and facilitator of our reimbursement

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot